Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.91
-0.08 (-1.14%)
At close: Feb 13, 2026, 4:00 PM EST
7.00
+0.09 (1.30%)
After-hours: Feb 13, 2026, 5:29 PM EST
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $42.52 million as of February 13, 2026. Its market cap has decreased by -51.74% in one year.
Market Cap
42.52M
Enterprise Value
-50.51M
1-Year Change
-51.74%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $42.52M, a decrease of -92.32%. That is a compound annual growth rate of -38.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 42.52M | -25.86% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 45.92M |
| Cingulate | 45.27M |
| CervoMed | 43.67M |
| OS Therapies | 42.96M |
| Xilio Therapeutics | 42.62M |
| Apollomics | 42.47M |
| CEL-SCI | 41.20M |
| Lite Strategy | 41.18M |